Biologik ApS: Financial statements 2024
CVR: 36070498
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
Biologik ApS (CVR 36070498) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 400,167 and a net result of DKK -35,348 compared with DKK 118,661 the year before. That is a decrease of 38.7% compared with the year before. Equity in the 2024 report amounted to DKK 235,079. The solvency ratio was 69%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 400,167
- Profit/Loss
- DKK -35,348
- Equity
- DKK 235,079
- Total Assets
- DKK 340,743
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 400 t. | -35 t. | 235 t. | 1 |
| 2023 | - | 653 t. | 119 t. | 329 t. | 1 |
| 2022 | - | 258 t. | -89 t. | 268 t. | 1 |
| 2021 | - | 593 t. | 215 t. | 414 t. | 1 |
| 2020 | - | 378 t. | 62 t. | 199 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout Biologik ApS
Biologik ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2014. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The management consists of Anette Sams Nielsen. The company is owned by Helms & Sams ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 385,601 and a net result of DKK 234,499 compared with DKK -35,348 the year before. Equity in the 2025 report amounted to DKK 408,578.